Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1

European Journal of Neurology

Volumn 15, Issue 9, 2008, Pages 947-952

  Winblad, S ^a   Mansson J E ^b   Blennow, K ^b   Jensen, C ^a   Samuelsson, L ^a   Lindberg, C ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

amyloid; Cerebrospinal fluid; Cognition; MRI; Myotonic dystrophy type 1; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MYOTONIC DYSTROPHY; NERVE CELL DEGENERATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION;

ADULT; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; BRAIN; CEREBRAL VENTRICLES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS;

EID: 49549092718     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02217.x     Document Type: Article

References (32)

1. Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscular Disorders 2005 15 : 5 16.
2. Meola G, Sansone V. Cerebral involvement in myotonic dystrophies. Muscle and Nerve 2007 36 : 294 306.
3. Blennow K, de Leon MJ, Zetterberg H. Alzheimers disease. Lancet 2006 368 : 387 403.
4. Kiuchi A, Otsuka N, Namba Y, Nakano I, Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathologica 1991 82 : 1 5.
5. Oyamada R, Hayashi M, Katoh Y, et al. Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 2006 2 : 107 114.
6. Maurage CA, Udd B, Ruchoux MM, et al. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 2005 10 : 1636 1638.
7. Sergeant N, Sablonnière B, Schraen-Maschke S, et al. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Human Molecular Genetics 2001 10 : 2143 2155.
8. Leroy O, Wang J, Maurage CA, et al. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochimica Biophysica Acta 2006 4 : 460 467.
9. Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neuroscience Letters 1997 256 : 210 212.
10. Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, Yamada M. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. Journal of Neurological Sciences 2005 237 : 61 65.
11. Grossman M, Farmer J, Leight S, et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Annals of Neurology 2005 57 : 721 729.
12. Holmberg B, Johnels B, Blennow K, Rosengren L. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy. Movement Disorders 2003 18 : 186 190.
13. Sjögren M, Davidsson P, Wallin A, et al. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms. Dementia and Geriatric Cognitive Disorders 2002 13 : 112 118.
14. Winblad S, Lindberg C, Hansen S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromuscular Disorders 2005 15 : 287 292.
15. Nordenskiöld U, Grimby G. Grip force in patients with rheumatoid arthtritis and fibromyalgia and in healthy subjects. A study with the Grippit instrument. Scandinavian Journal of Rheumatology 1993 22 : 14 19.
16. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease- specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001 56 : 336 340.
17. Sjögren M, Vanderstichele H, Ågren H, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clinical Chemistry 2001 47 : 1776 1781.
18. Vanmechelen E, Vanderstichele H, Davidsson P, et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neuroscience Letters 2000 285 : 49 52.
19. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′-end of a transcript encoding a protein kinase family member. Cell 1992 68 : 799 808.
20. di Costanzo A, Di Salle F, Santoro L, Tessitore A, Bonavita V, Tedschi G. Pattern and significance of white matter abnormalities in myotonic dystrophy type 1: an MRI study. Journal of Neurology 2002 249 : 1175 1182.
21. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. American Journal Roentegenology 1987 149 : 351 356.
22. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. Journal of Neurological Science 1993 114 : 7 12.
23. Wechsler D. Wechsler Adult Intelligence Scale - Revised (WAIS-R). San Antonio : The Psychological Corporation, 1982.
24. Schmidt M. Rey Auditory Verbal Learning Test. A Handbook. Los Angeles : Western Psychological Services, 1996.
25. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Archives of Clinical Neuropsychology 1999 2 : 167 177.
26. Fastenau PS, Denburg NL, Hufford BJ. Adult norms for the Rey-Osterieth Complex Figure Test and for supplemental recognition and matching trials from the extended complex figure test. Clinical Neuropsychology 1999 1 : 30 47.
27. Tombaugh T. Trail Making Test A and B: normative data stratified by age and education. Archives of Clinical Neuropsychology 2004 19 : 203 214.
28. Grant DA, Berg EA, Nyman H. Wisconsin Card Sorting Test. WCST - Revised and Expanded. Stockholm : Psykologiförlaget, 1996.
29. Mitrushina M, Boone KB, Razani J, D'Elia LF. Handbook of Normative Data for Neuropsychological Assessment. New York : Oxford University Press, 2005 : 108 133.
30. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979 6 : 65 70.
31. Wahlund LO, Blennow K. Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neuroscience Letters 2003 339 : 99 102.
32. Winblad S, Lindberg C, Hansen S. Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy (DM1). Behaviour and Brain Functions 2006 2 : 16.